
InsideArbitrage September 2023 Mid-Month Update – A High Growth Tech Company
We have been generating a lot of content in recent months and sometimes it can get overwhelming for our readers and at times overwhelming for
Read MoreWe have been generating a lot of content in recent months and sometimes it can get overwhelming for our readers and at times overwhelming for
Read MoreSplit-offs and the McDonald’s – Chipotle Example In 2006 McDonald’s (MCD) decided to spin-off its Mexican fast casual chain Chipotle (CMG) in a series of
Read MoreArbitrageurs were delighted last week when a federal judge rejected the FTC’s request to block Microsoft’s massive $69 billion acquisition of Activision Blizzard (ATVI). By
Read MoreWe have discussed arbitrage situations that include a special kicker in the form of contingent value rights or CVRs several times in the past. The
Read MoreEvery eight to ten years, we seem to find ourselves in some sort of crisis. The crisis often follows a bubble and different investors react
Read MoreWe started tracking pre-merger announcements or rumored deals in 2017 and called them “deals in the works” (DITW). One of the advantages of collecting data
Read MoreOver the last three years, I have added several ideas to our watchlist that I liked but wanted to follow for a while or pick
Read MoreOur History With B. Riley Instead of focusing on a new idea for our February 2023 mid-month update, I decided to revisit one of our
Read MoreEditor’s Note: When we discussed the 1Life Healthcare (ONEM) arbitrage opportunity in the August 2022 Special Situations newsletter the spread on the deal was almost the
Read MoreWe started the year discussing a basket of “Broken Growth” stocks that had declined anywhere from 50% to 70% from their peaks and looking at
Read MoreIn our May 2022 Mid-Month Update for Inside Arbitrage Premium and Plus members, we discussed the acquisition of Biohaven Pharmaceuticals by Pfizer (PFE) and wrote
Read MoreSummary: Both the Biohaven deal discussed in our May 2022 Mid-Month update and the Bluerock Residential Growth REIT deal discussed in our January 2022 Special
Read More